Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults

摘要

The present technology relates to a method for reducing the seizure frequency of a subject with epilepsy, wherein the frequency of seizures is reduced by transdermal administration of an effective amount of cannabidiol (CBD) to a subject with epilepsy.